PARIS & ATLANTA--(BUSINESS WIRE)--biospace med, the orthopaedic imaging company, announced today the closing of $18 million (12 m€) in venture capital financing led by NBGI Ventures (London) and Crédit Agricole Private Equity (Paris). Edmond de Rothschild Investment Partners (Paris) and UFG PE (Paris), current investors in the company, also have subscribed to the current round of financing. Aelios Finance served as financial advisor to biospace med.
